Benefits of extended‐release memantine in moderate‐to‐severe Alzheimer\'s Disease as a function of disease severity: post hoc analysis from a randomized trial.

Aún no traducido Aún no traducido
Categoría Estudio primario
RevistaAnnals of Neurology 2013;Conference: 138th Annual Meeting of the American Neurological Association, ANA 2013 New Orleans, LA United States. Conference Start: 20131013 Conference End: 20131015. Conference Publication:S92‐3
Año 2013
Este artículo no tiene resumen
Epistemonikos ID: 1e792ffcf60fdd5205e022e7886928865cf9e7a2
First added on: Jan 21, 2021